Feldene Related Published Studies
Well-designed clinical trials related to Feldene (Piroxicam)
A clinical comparison of topical piroxicam and EMLA cream for pain relief and inflammation in laser hair removal. [2009.07]
Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study. [2009]
Double-blind, placebo-controlled, randomized clinical trial of sublingual or intramuscular piroxicam in the treatment of renal colic. A comparative study. [2007]
[Randomized study comparing piroxicam analgesia and tramadol analgesia during outpatient electromagnetic extracorporeal lithotripsy] [2006.04]
Sublingual piroxicam for postoperative analgesia: preoperative versus postoperative administration: a randomized, double-blind study. [2006.03]
Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. [2006.02]
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction. [2005.12]
Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the cat. [2005.10]
Pharmacokinetic profiles of two tablet formulations of piroxicam. [2005.05.13]
Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study. [2005.03]
Well-designed clinical trials possibly related to Feldene (Piroxicam)
Effect of locally administered lornoxicam in the management of low back pain after lumbar epidural anesthesia: a double-blind, randomized, controlled study. [2009.09]
'Scheduled' dosing of lornoxicam provides analgesia superior to that provided by 'on request' dosing following craniotomy. [2009.08]
Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms. [2009.08]
Tenoxicam controls pain without altering orthodontic movement of maxillary canines. [2009.02]
Pharmacogenetic relevance of the CYP2C9*3 allele in a tenoxicam bioequivalence study performed on Spaniards. [2009.01]
Addition of dexmedetomidine or lornoxicam to prilocaine in intravenous regional anaesthesia for hand or forearm surgery : a randomized controlled study. [2009]
Ketamine and lornoxicam for preventing a fentanyl-induced increase in postoperative morphine requirement. [2008.12]
[Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin] [2008.11]
[The effect of three different lornoxicam administrations on postoperative analgesia] [2008.10]
[Comparison of analgesic activity of intraarticular lornoxicam, bupivacaine and saline after knee arthroscopy] [2008.10]
Preemptive analgesia by lornoxicam--an NSAID--significantly inhibits perioperative platelet aggregation. [2008.09]
Lornoxicam attenuates the haemodynamic responses to laryngoscopy and tracheal intubation in the elderly. [2008.09]
The analgesic effect of 8 and 16 mg lornoxicam administered before shock wave lithotripsy: a randomized, double-blind, controlled study. [2008.08]
Lornoxicam characteristically modulates cerebral pain-processing in human volunteers: a functional magnetic resonance imaging study. [2008.06]
The preemptive analgesic effect of lornoxicam in patients undergoing major abdominal surgery: a randomised controlled study. [2008.06]
Patient-controlled analgesia with lornoxicam vs. dipyrone for acute postoperative pain relief after septorhinoplasty: a prospective, randomized, double-blind, placebo-controlled study. [2008.03]
Efficacy of lornoxicam for acute postoperative pain relief after septoplasty: a comparison with diclofenac, ketoprofen, and dipyrone. [2008.03]
Efficacy of levobupivacaine wound infiltration with and without intravenous lornoxicam for post-varicocoele analgesia : a randomized, double-blind study. [2008]
Comparative bioavailability of lornoxicam as single doses of quick-release tablet, standard tablet and intramuscular injection: a randomized, open-label, crossover phase I study in healthy volunteers. [2008]
Comparison of lornoxicam versus tramadol analgesia for transrectal prostate biopsy: a randomized prospective study. [2008]
Lornoxicam in extracorporeal shock-wave lithotripsy; comparison with tenoxicam and placebo in terms of analgesic consumption. [2008]
Analgesic efficacy of quick-release versus standard lornoxicam for pain after third molar surgery: a randomized, double-blind, placebo-controlled, single-dose trial. [2008]
Intra-articular injection of tenoxicam in osteoarthritic knee joints with effusion. [2007.12]
Comparison of analgesic and anti-inflammatory efficacy of selective and non-selective cyclooxygenase-2 inhibitors in dental implant surgery. [2007.12]
The analgesic efficacy of preoperative versus postoperative lornoxicam in varicocele repair. [2007.12]
Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. [2007.10.17]
[Comparison of tramadol, tramadol-metamizol and tramadol-lornoxicam administered by intravenous PCA in management of postoperative pain] [2007.10]
Comparison of effects of preoperatively administered lornoxicam and tenoxicam on morphine consumption after laparoscopic cholecystectomy. [2007.08]
WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee. [2007.07.18]
Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. [2007.07]
Analgesic effects of lornoxicam after total abdominal hysterectomy. [2007.05]
Recompression and adjunctive therapy for decompression illness. [2007.04.18]
Efficacy of lornoxicam in postoperative analgesia after total knee replacement surgery. [2007.04]
A comparison of pre-emptive analgesic efficacy of diflunisal and lornoxicam for postoperative pain management: a prospective, randomized, single-blind, crossover study. [2007.02]
Parecoxib vs. lornoxicam in the treatment of postoperative pain after laparoscopic cholecystectomy: a prospective randomized placebo-controlled trial. [2007.02]
Lornoxicam and ondansetron for the prevention of intrathecal fentanyl-induced pruritus. [2007]
Pain after elective arthroscopy of the knee: a prospective, randomised, study comparing conventional NSAID to coxib. [2006.11]
The analgesic effect of lornoxicam when added to lidocaine for intravenous regional anaesthesia. [2006.09]
Articaine and mepivacaine efficacy in postoperative analgesia for lower third molar removal: a double-blind, randomized, crossover study. [2006.08]
Which has the least immunity depression during postoperative analgesia--morphine, tramadol, or tramadol with lornoxicam? [2006.07.15]
Postoperative analgesic effects of lornoxicam after thyroidectomy: a placebo controlled randomized study. [2006.04]
The effect of pre-operative lornoxicam and ketoprofen application on the morphine consumption of post-operative patient-controlled analgesia. [2006.03]
Comparison of intra-articular tenoxicam and oral tenoxicam for pain and physical functioning in osteoarthritis of the knee. [2006.02]
Comparison of lornoxicam with tramadol in patient-controlled analgesia after gynecological surgery. [2006]
Analgesic efficacy and safety of lornoxicam quick-release formulation compared with diclofenac potassium: randomised, double-blind trial in acute low back pain. [2006]
Infiltration with ropivacaine plus lornoxicam reduces postoperative pain and opioid consumption. [2005.12]
Intraarticular analgesia after arthroscopic knee surgery: comparison of neostigmine, clonidine, tenoxicam, morphine and bupivacaine. [2005.11]
Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. [2005.06]
Application of lornoxicam to patient-controlled analgesia in patients undergoing abdominal surgeries. [2005.03]
Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype. [2005.01]
A non-extracting procedure for the determination of meloxicam in plasma samples by HPLC-diode array detection. [2005]
Other research related to Feldene (Piroxicam)
Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trials. [2009.10]
Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. [2009.05]
Influence of surfactants of Rofam type on properties of piroxicam tablets. [2009.03]
The effects of piroxicam in the attenuation of MPP+/MPTP toxicity in vitro and in vivo. [2009.02]
Anti-inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam. [2009.01]
Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings. [2009.01]
Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats. [2008.11]
Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. [2008.11]
Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain. [2008.10]
The effect of piroxicam on the formation of postoperative, intraabdominal adhesion in rats. [2008.10]
A clinical comparison of topical piroxicam and EMLA cream for pain relief and inflammation in laser hair removal. [2008.08.21]
Preparation and in vivo evaluation of piroxicam-loaded gelatin microcapsule by spray drying technique. [2008.06]
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability. [2008.05.22]
Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations. [2008.05.19]
The effect of piroxicam on the prevention of postoperative retrosternal and pericardial adhesions. [2007.12]
Cystic nasal adenocarcinoma in a cat treated with piroxicam and chemoembolization. [2007.11]
Piroxicam increases colon tumorigenesis and promotes apoptosis in Mlh1 +/- /Apc1638(N/+) mice. [2007.11]
Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. [2007.10.01]
The selective and non-selective cyclooxygenase inhibitors valdecoxib and piroxicam induce the same postoperative analgesia and control of trismus and swelling after lower third molar removal. [2007.08]
Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. [2007.07]
Impact of piroxicam beta-cyclodextrin on the efficacy of the intrauterine device in a rat model. [2007.06]
Electrochemical monitoring of piroxicam in different pharmaceutical forms with multi-walled carbon nanotubes paste electrode. [2007.05.09]
Effect of piroxicam gel for pain control and inflammation in Nd:YAG 1064-nm laser hair removal. [2007.03]
Polyelectrolyte complexes of Eudragit l30 d-55 and gelatin: antinociceptive activity of entrapped piroxicam. [2007.03]
Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. [2007.01]
Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma. [2006.10.15]
Morphological changes in the liver after the administration of piroxicam and its complexes with Bio-Ions Cu (II), Co (II), Zn (II) to the rats. [2006.10]
Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery. [2006.09]
Synthesis and thermal characterization of new ternary chelates of piroxicam and tenoxicam with glycine and DL-phenylalanine and some transition metals. [2006.05.01]
Pharmacodynamics of piroxicam from self-emulsifying lipospheres formulated with homolipids extracted from Capra hircus. [2006.03]
Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma. [2006.02.15]
The in vitro effects of piroxicam and meloxicam on canine cell lines. [2006.01]
Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases. [2005.12]
Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. [2005.11.05]
Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam. [2005.10]
Influence of cyclodextrin complexation on piroxicam gel formulations. [2005.09]
Topical absorption of piroxicam from organogels--in vitro and in vivo correlations. [2005.07.14]
Enhanced bioavailability of piroxicam via salt formation with ethanolamines. [2005.06.13]
[Clinical study on the tolerance and efficacy of piroxicam used in cataract surgery, compared with diclofenac and indomethacin] [2005.04]
Effect of piroxicam, metamizol, and S-adenosylmethionine in a murine model of experimental trichomoniasis. [2005.03]
|
